Literature DB >> 31085076

Cross-link is a risk factor for rod fracture at pedicle subtraction osteotomy site: A finite element study.

Tae Hyun Park1, Su Heon Woo2, Sung Jae Lee3, Dong Min Sohn3, Chun Kee Chung4, Yongjung Jay Kim5, Seil Sohn6.   

Abstract

BACKGROUND: We aim to investigate using finite element model (FEM) whether the use of a cross-link is a risk factor for rod fracture at the pedicle subtraction osteotomy (PSO) site.
METHODS: The geometry and dimensions of the FEM were obtained from a high-resolution computed tomography scan data of a 65 years old female patient with spinal sagittal imbalance. The intact model was modified to place PSO on the L4 spine. A cross-link was placed at the PSO site. A multisegment spinal fusion model from L1 to the pelvis was used to compare and analyze the peak von Mises stress (PVMS) values of the implants. A compressive follower load of 400 N was added to the validated intact lumbar spinal model in the follower load path direction.
RESULTS: After PSO surgery, the PVMS of the rod was significantly increased during flexion and extension at the PSO site. With the cross-link at the PSO site, the PVMS of the rod was further significantly increased during flexion and extension.
CONCLUSION: The cross-link at the PSO site increased the risk of rod facture, especially during flexion and extension stress.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cross-link; Finite element analysis; PSO; Rod fracture; Spine

Mesh:

Year:  2019        PMID: 31085076     DOI: 10.1016/j.jocn.2019.04.036

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  1 in total

1.  Biomechanical Evaluation of the Cross-link Usage and Position in the Single and Multiple Segment Posterior Lumbar Interbody Fusion.

Authors:  Lin Han; Haisong Yang; Yongheng Li; Zhiyong Li; Hongdao Ma; Chenfeng Wang; Jincan Yuan; Luyu Zheng; Qiang Chen; Xuhua Lu
Journal:  Orthop Surg       Date:  2022-09-14       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.